NVST

As of 2026-09-10, NVST scores 49out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. NVST trades at $25.87, within its fair-value band.

NVST scores 49 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 49. Its strongest factor is value at 86 (exceptional), where it screens cheap on the model's valuation inputs, followed by sentiment at 48. The weakest is momentum at 39, where price trend is the soft spot. Among Healthcare stocks it ranks in roughly the top 37% of the Healthcare names the model scores.

On valuation, NVST is priced in the lower part of its recent range. The profile is lopsided — a few factors carry it while others drag, so the composite masks real disagreement underneath. The blended composite before the macro overlay was 51. Same-sector names the model rates nearby include HALO, THC, TGTX.

This is a descriptive factor read on NVST, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where NVST sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for NVST runs $23.03–$32.81. Current price $25.87 sits within its fair-value band. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.